An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Clinical trial NCT07665437 · RECRUITING
Trial details
- NCT number
- NCT07665437
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-10
- Primary completion
- 2031-10-27
- Enrollment
- 710
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.